287 related articles for article (PubMed ID: 36875133)
1. Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases.
Santos FM; Ciordia S; Mesquita J; Cruz C; Sousa JPCE; Passarinha LA; Tomaz CT; Paradela A
Front Immunol; 2023; 14():1107295. PubMed ID: 36875133
[TBL] [Abstract][Full Text] [Related]
2. The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease.
Schori C; Trachsel C; Grossmann J; Zygoula I; Barthelmes D; Grimm C
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD31-AMD40. PubMed ID: 30025106
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
[TBL] [Abstract][Full Text] [Related]
4. Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases.
Dos Santos FM; Ciordia S; Mesquita J; de Sousa JPC; Paradela A; Tomaz CT; Passarinha LAP
Cell Mol Life Sci; 2022 Dec; 80(1):22. PubMed ID: 36585968
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration.
Ioanna Z; Christian S; Christian G; Daniel B
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):325-332. PubMed ID: 29177891
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal neurodegenerative and inflammatory mediators in proliferative diabetic retinopathy.
Mallmann F; Canani LH
Arq Bras Oftalmol; 2019; 82(4):275-282. PubMed ID: 30970121
[TBL] [Abstract][Full Text] [Related]
7. Systems pathology analysis identifies neurodegenerative nature of age-related vitreoretinal interface diseases.
Öhman T; Tamene F; Göös H; Loukovaara S; Varjosalo M
Aging Cell; 2018 Oct; 17(5):e12809. PubMed ID: 29963742
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy.
Shahulhameed S; Vishwakarma S; Chhablani J; Tyagi M; Pappuru RR; Jakati S; Chakrabarti S; Kaur I
Front Immunol; 2020; 11():154. PubMed ID: 32117292
[TBL] [Abstract][Full Text] [Related]
9. Examining the correlation of lymphangiogenesis biomarkers with clinical condition in Age-Related Macular Degeneration (AMD).
Cakir Ince BA; Kucukevcilioglu M; Yucel C; Durukan AH
Exp Eye Res; 2024 Jun; 243():109891. PubMed ID: 38615832
[TBL] [Abstract][Full Text] [Related]
10. A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.
Cehofski LJ; Honoré B; Vorum H
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452939
[TBL] [Abstract][Full Text] [Related]
11. Circulating MicroRNAs as Biomarker for Vessel-Associated Retinal Diseases.
Dähmcke M; Busch M; Pfeil JM; Brauckmann T; Schulz D; Omran W; Morawiec-Kisiel E; Wähler F; Paul S; Tayar A; Bründer MC; Grundel B; Stahl A
Ophthalmologica; 2023; 246(3-4):227-237. PubMed ID: 37721532
[TBL] [Abstract][Full Text] [Related]
12. In-Depth Molecular Characterization of Neovascular Membranes Suggests a Role for Hyalocyte-to-Myofibroblast Transdifferentiation in Proliferative Diabetic Retinopathy.
Boneva SK; Wolf J; Hajdú RI; Prinz G; Salié H; Schlecht A; Killmer S; Laich Y; Faatz H; Lommatzsch A; Busch M; Bucher F; Stahl A; Böhringer D; Bengsch B; Schlunck G; Agostini H; Lange CAK
Front Immunol; 2021; 12():757607. PubMed ID: 34795670
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.
Gao BB; Chen X; Timothy N; Aiello LP; Feener EP
J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156
[TBL] [Abstract][Full Text] [Related]
14. System-wide vitreous proteome dissection reveals impaired sheddase activity in diabetic retinopathy.
Alli-Shaik A; Qiu B; Lai SL; Cheung N; Tan G; Neo SP; Tan A; Cheung CMG; Hong W; Wong TY; Wang X; Gunaratne J
Theranostics; 2022; 12(15):6682-6704. PubMed ID: 36185601
[No Abstract] [Full Text] [Related]
15. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
17. Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.
Wei Q; Zhang T; Jiang R; Chang Q; Zhang Y; Huang X; Gao X; Jin H; Xu G
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5783-5791. PubMed ID: 29117316
[TBL] [Abstract][Full Text] [Related]
18. [New exploration of treatment target for proliferative diabetic retinopathy based on iTRAQ LC-MS/MS Proteomics].
Wen DJ; Ren XJ; Dong LJ; He Y; Li XR
Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):769-776. PubMed ID: 31607066
[No Abstract] [Full Text] [Related]
19. Epiretinal membranes and incomplete posterior vitreous detachment in diabetic macular edema, detected by spectral-domain optical coherence tomography.
Ophir A; Martinez MR
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6414-20. PubMed ID: 21730347
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration.
Rinsky B; Beykin G; Grunin M; Amer R; Khateb S; Tiosano L; Almeida D; Hagbi-Levi S; Elbaz-Hayoun S; Chowers I
Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):18. PubMed ID: 34406330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
